Fentanyl (Effentora)
Fentanyl
Teva Pharmaceuticals (Pty) Ltd
Registration
- Applicant
- Teva Pharmaceuticals (Pty) Ltd
- Certificate holder
- Teva Pharmaceuticals (Pty) Ltd
- Registrations
- 5
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Effentora 100 | 100Effervescent buccal tablets. | 48005448/2.9/0054Approved 18 February 2025 | Registered | Not determined | PIPIL |
| Effentora 200 | 200Effervescent buccal tablets. | 48005548/2.9/0055Approved 18 February 2025 | Registered | Not determined | PIPIL |
| Effentora 400 | 400Effervescent buccal tablets. | 48005648/2.9/0056Approved 18 February 2025 | Registered | Not determined | PIPIL |
| Effentora 600 | 600Effervescent buccal tablets. | 48005748/2.9/0057Approved 18 February 2025 | Registered | Not determined | PIPIL |
| Effentora 800 | 800Effervescent buccal tablets. | 48005848/2.9/0058Approved 18 February 2025 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S6: Fentanyl
- when intended for therapeutic purposes.
Consolidated Schedules 06 July 2026, line 10256
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide
Drag to rotate. Structure from PubChem CID 3345.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.